ESC 365 - Professor William Abraham

Speaker illustration

Professor William Abraham

The Ohio State University, Columbus (United States of America)

Member of:

Heart Failure Association

Dr. Abraham earned his MD from Harvard Medical School and completed post-graduate training in Internal Medicine, Cardiovascular Medicine, and Advanced Heart Failure/Transplant Cardiology at the University of Colorado. At Ohio State University, Dr. Abraham is a College of Medicine Distinguished Professor. He has been recognized as one of the “Best Doctors in America” for 18 consecutive years. His research has led to the approval/adoption of new heart failure therapies, including beta-blockers, natriuretic peptides, cardiac resynchronization therapy, ultrafiltration, implantable hemodynamic monitoring, transvenous phrenic nerve stimulation, cardiac contractility modulation, baroreflex activation therapy, and mitral valve repair. He has authored more than 1,000 original works and been named a Clarivate Analytics Highly Cited Researcher and one of The World’s Most Influential Scientific Minds. He received the 2017 Distinguished Scientist Award from the American College of Cardiology.

Sessions Presentations Articles

Unlocking the potential of baroreflex activation in heart failure patients

Event: Heart Failure 2023

Topic: Device Therapy

Session type: Satellite Symposium

Cardiac resynchronization therapy

Event: Heart Failure 2023

Topic: Cardiac Resynchronisation Therapy (CRT)

Session type: Clinical Cases

Acute heart failure - Biomarkers

Event: ESC Congress 2022

Topic: Biomarkers

Session type: Moderated ePosters

Diagnostic and prognostic value of biomarkers in acute heart failure

Event: Heart Failure 2022

Topic: Biomarkers

Session type: Symposium

Big Brother is watching you: role of telemonitoring in the management of advanced heart failure.

Event: Heart Failure 2022

Topic: Remote Patient Monitoring and Telehealth

Session type: HowTo

Rapid parade of devices: emerging treatment options in heart failure, Part 2

Event: Heart Failure 2021

Topic: Treatment

Session type: Special Session

Expert opinion on heart failure management: devices

Event: Heart Failure 2021

Topic: Chronic Heart Failure

Session type: Special Session

Treating common comorbidities (iron deficiency and sleep apnoea)

Event: Heart Failure 2021

Topic: Chronic Heart Failure

Session type: Symposium

Transcatheter mitral valve repair in functional mitral regurgitation : time for evidence!

Event: ESC Congress 2018

Topic: Valvular Heart Disease

Session type: Satellite Symposium

Functional mitral and tricuspid regurgitation: will novel transcatheter options redefine the landscape?

Event: Heart Failure 2018

Topic: Valvular Heart Disease

Session type: Satellite Symposium

ESC 365 is supported by